Goldman Sachs expects Westlife’s same-store sales growth (SSSG) to start recovering in the second half of FY25, aided by a soft base. It has forecast…

Suzlon’s outperformance was driven by the strong increase in order book and its improved balance sheet along with cash flows from operations. Suzlon’s order book…

Marketbuzz Podcast: The Indian market is likely to start in green tracking global cues with a focus on IT stocks. Tune in to the podcast…

UBS has initiated coverage on Zydus Lifesciences Ltd. and Dr Reddy’s Laboratories Ltd. with a ‘Sell’ recommendation, setting price targets of ₹850 and ₹5,700 per…

Goldman Sachs is anticipating Gland Pharma’s profitability to face headwinds. It has highlighted five factors as to why it believes so.

Nuvama Wealth Management Share Price | On Thursday, September 26, CNBC-TV18 reported, citing sources, that Edel Finance Company and Ecap Equities were to sell a…

On Friday, market tech analysts Mitessh Thakkar and Shrikant Chouhan recommended these stocks for the short term.

Indian IT stocks are the top gainers on the Nifty 50 index today, with LTIMindtree leading with a surge of 3%, while Tech Mahindra, Infosys,…

The Nifty 50 is currently trading at 21.5 times its one-year forward earnings whereas the KOSPI commands a valuation of 8.8 times.

Swiggy has a high attrition rate over the last three fiscals as highlighted in its DRHP. Read on to know more about the risk factors.